NCCN Publishes New Guide to Improving Knowledge and Quality of Life for Small Cell Lung Cancer Patients

NCCN announces the publication of new NCCN Guidelines for Patients®: Small Cell Lung Cancer (SCLC), which is a neuroendocrine tumor type of lung cancer that is linked to smoking and tends to be aggressive. This guide is free to view or download at NCCN.org/patientguidelines and is funded by NCCN Foundation®.

New Patient Guide from NCCN Jumpstarts Important Conversations About Anal Cancer

New and updated patient and caregiver resources from National Comprehensive Cancer Network (NCCN) offer jargon-free, state-of-the-art information on diagnosis, treatment, and surveillance for anal, colon, and rectal cancers.

Patrick Delaney Named New Executive Director of NCCN Foundation

The National Comprehensive Cancer Network® (NCCN®) today announced the appointment of Patrick Delaney as incoming Executive Director for the NCCN Foundation®. Delaney has previously held leadership roles with the Juvenile Diabetes Research Foundation, American Red Cross, and American Cancer Society.

New Resource for Survivors from NCCN Helps Guide Life After Cancer Diagnosis and Treatment

NCCN announces the publication of new, free informational resources on health and wellness for cancer survivors. Two new NCCN Guidelines for Patients® focus on healthy living and managing late and long-term side effects, and include appropriate ongoing screening for recurrence.

New NCCN Resource for Understanding Childhood Leukemia

NCCN publishes a new patient and caregiver resource focused on a childhood cancer type. Free NCCN Guidelines for Patients: Pediatric Acute Lymphoblastic Leukemia (ALL) shares the latest expert advice for treating infants, children, and adolescents with the most common pediatric malignancy.

NCCN: What People with Cancer and their Caregivers Need to Know about CAR T-Cell Therapy

The National Comprehensive Cancer Network (NCCN) has published a new NCCN Guidelines for Patients: Immunotherapy Side Effects focused on chimeric antigen receptor (CAR) T-cell therapy. This is book two in a series that includes another book on irAEs focused on immune checkpoint inhibitors.

How to Recognize Side-Effects from Immunotherapy? New NCCN Guidelines for Patients can Help

New NCCN Guidelines for Patients: Immunotherapy Side Effects – Immune Checkpoint Inhibitors from National Comprehensive Cancer Network and NCCN Foundation shares information for patients and caregivers on how to recognize and manage adverse events from immune checkpoint inhibitors.

New Information from NCCN on Overcoming Challenges for People with Head and Neck Cancers

Newly-completed series of patient guidelines from National Comprehensive Cancer Network (NCCN) shares expert advice with patients and caregivers on treatment and prevention for most common head and neck cancers, including some that are HPV-related.

NCCN Prostate Cancer Patient Guidelines Listed among Top Global Sources for Trustworthy Online Information

A recently-published, independent, peer-reviewed, international study in Current Urology measured reliability and transparency of online medical information for people with prostate cancer and their caregivers, and found the NCCN Guidelines for Patients® to be one of the most trustworthy resources.

NCCN

New Patient Resource from NCCN Helps People with Bladder Cancer Make Informed Treatment Decisions

New NCCN Guidelines for Patients: Bladder Cancer explains the lengthy surveillance process that follows active treatment for the sixth most-common cancer in the United States. PLYMOUTH MEETING, PA [June 26, 2019] — The treatment landscape for bladder cancer has changed…